Replies to post #426462 on Anavex Life Sciences Corp (AVXL)

[tredenwater2]

George I like the comment by Sandra (8:30 mark) about the increase in R&D expense QoQ due to increase in management team, drug manufacturing for trials and “potential market supply”.

All good stuff. WGT and it looks like in “the second half of this year” which we ARE in.

Tred